Clinical Trial

Effectiveness of a Novel Scoliosis Therapy Using a Standing Scoliosis Therapy Device With Biological Feedback Mechanism

Completed
View on ClinicalTrials.gov →
Summary
This study evaluates the effectiveness of a novel standing scoliosis therapy device with a biofeedback mechanism in children and adolescents with adolescent idiopathic scoliosis (AIS). Participants are assigned to one of three groups: SkolioMaster (prototype device), Skol-As therapy, or the FITS method. The primary objective is to assess whether the device reduces spinal curvature (Cobb angle). Secondary objectives include evaluating its effects on other physical outcomes. Participants will attend rehabilitation sessions twice weekly for six months and undergo clinical and radiographic assessments.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-06.
Trial Details
NCT Number NCT07585110
Lead Sponsor Centrum Medyczne Katarzyna Smółka
Collaborators: Małopolskie Centre of Entrepreneurship
Conditions Idiopathic Scoliosis
Enrollment 32 participants
Start Date 2021-07-05
Primary Completion 2023-03-17 (estimated)
Study Completion 2023-04-14 (estimated)
Updated on ClinicalTrials.gov 2026-05-20